← Leaderboards

Michael T Lewis

University Of Colorado Denver

Google Scholar ↗PubMed ↗ORCID ↗

$21,208,742

Attributed

$26,312,793

Total exposure

19

Grants

13

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.1M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$40,828,210 · 21

By mechanism

U54$22,886,072 · 9

R01$7,186,229 · 3

U01$3,333,657 · 2

U24$3,165,237 · 1

P01$2,990,265 · 3

P30$1,266,750 · 3

Top collaborators

Most similar at University Of Colorado Denver

Same institution · by research overlap

Heide L Ford$14,422,349
Kathleen O'Neill$421,117
Alan Michael Elder$284,216
Joan E Hooper$2,545,898
Jacob Gadwa$37,384

Others in their field

Top investigators on “Tumor”

David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
Richard K. Wilson · Washington University$203,917,615
Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819

Research focus

TumorMalignant NeoplasmsMolecularResponseMalignant Breast NeoplasmIn VivoCellsClinical TrialsBaseCollectionXenograft ProcedureBreastLaboratoriesSiteFundingProteinsChemotherapySignal TransductionResearch Project GrantsAnimalsXenograft ModelTransplantationGenesResistance

Grant awards (93)

PDX Trial Center for Breast Cancer Therapy$1,144,535

U54 · FY2025 · CA

Research Project 1: Enhancing neoadjuvant therapy to prevent breast cancer recurrence$395,341

U54 · FY2025 · CA · contact PI

Patient-Derived Xenograft Shared Resource$108,410

P30 · FY2025 · CA · contact PI

PDX Core$43,883

U54 · FY2025 · CA · contact PI

PDX Trial Center for Breast Cancer Therapy$996,258

U54 · FY2024 · CA

Research Project 1: Enhancing neoadjuvant therapy to prevent breast cancer recurrence$375,574

U54 · FY2024 · CA · contact PI

Advanced in Vivo Cancer Models$232,806

P30 · FY2024 · CA · contact PI

PDX Core$48,050

U54 · FY2024 · CA · contact PI

PDX Trial Center for Breast Cancer Therapy$1,187,139

U54 · FY2023 · CA

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER$620,231

U24 · FY2023 · CA · contact PI

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis$601,506

R01 · FY2023 · CA

Advanced in Vivo Cancer Models$232,806

P30 · FY2023 · CA · contact PI

PDX Core$197,857

U54 · FY2023 · CA · contact PI

Research Project 1: Enhancing neoadjuvant therapy to prevent breast cancer recurrence$197,856

U54 · FY2023 · CA · contact PI

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER$620,234

U24 · FY2022 · CA · contact PI

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis$601,506

R01 · FY2022 · CA

PDX Trial Center for Breast Cancer Therapy$520,759

U54 · FY2022 · CA

Advanced in Vivo Cancer Models$232,806

P30 · FY2022 · CA · contact PI

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance$223,982

U54 · FY2022 · CA · contact PI

Core-001$200,000

U54 · FY2022 · CA

Core-001$200,000

U54 · FY2022 · CA

Tolinapant efficacy in a subset of triple negative breast cancers$200,000

U54 · FY2022 · CA

Targeting mitochondrial dependencies in chemo resistant triple negative breast cancer$200,000

U54 · FY2022 · CA

PDX Trial Center for Breast Cancer Therapy$1,240,619

U54 · FY2021 · CA

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER$632,898

U24 · FY2021 · CA · contact PI

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis$613,781

R01 · FY2021 · CA

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance$467,118

U54 · FY2021 · CA · contact PI

Advanced in Vivo Cancer Models$227,116

P30 · FY2021 · CA · contact PI

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer$187,791

U01 · FY2021 · CA

Multi-omic, Exposure-informed, Genealogical Approach (mErGE)$119,886

U54 · FY2021 · CA

PDX Trial Center for Breast Cancer Therapy$1,240,654

U54 · FY2020 · CA

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis$694,114

R01 · FY2020 · CA

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER$632,900

U24 · FY2020 · CA · contact PI

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance$467,134

U54 · FY2020 · CA · contact PI

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer$436,457

U01 · FY2020 · CA

Advanced in Vivo Cancer Models$232,806

P30 · FY2020 · CA · contact PI

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer$147,634

U01 · FY2020 · CA

PDX Trial Center for Breast Cancer Therapy$120,000

U54 · FY2020 · CA

PDX Trial Center for Breast Cancer Therapy$119,960

U54 · FY2020 · CA

PDX Trial Center for Breast Cancer Therapy$1,240,654

U54 · FY2019 · CA

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER$658,974

U24 · FY2019 · CA · contact PI

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis$627,656

R01 · FY2019 · CA

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer$541,311

U01 · FY2019 · CA

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance$449,562

U54 · FY2019 · CA · contact PI

PDX Trial Center for Breast Cancer Therapy$62,293

U54 · FY2019 · CA

Project-002$44,780

U01 · FY2019 · CA

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis$29,978

R01 · FY2019 · CA

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance$10,381

U54 · FY2019 · CA · contact PI

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer$822,049

U01 · FY2018 · CA

PDX Trial Center for Breast Cancer Therapy$176,157

U54 · FY2018 · CA

PDX Trial Center for Breast Cancer Therapy$175,435

U54 · FY2018 · CA

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance$29,359

U54 · FY2018 · CA · contact PI

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance$29,238

U54 · FY2018 · CA · contact PI

PDX Trial Center for Breast Cancer Therapy$2,482,191

U54 · FY2017 · CA

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance$950,348

U54 · FY2017 · CA · contact PI

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer$565,399

U01 · FY2017 · CA

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer$588,236

U01 · FY2016 · CA

BCM - LAB$1,038,888

U54 · FY2014 · CA · contact PI

Education, Training, and Outreach Program$192,348

U54 · FY2014 · CA · contact PI

BCM - LAB$1,162,309

U54 · FY2013 · CA · contact PI

Education, Training, and Outreach Program$222,117

U54 · FY2013 · CA · contact PI

BCM - LAB$1,565,616

U54 · FY2012 · CA · contact PI

Targeting Notch, PI3K-AKT and Other Novel Pathways in Breast Cancer Stem Cells$433,884

R01 · FY2012 · CA

Regulation of Mammary Stem Cells$308,958

R01 · FY2012 · CA · contact PI

Education, Training, and Outreach Program$270,122

U54 · FY2012 · CA · contact PI

Regulation of Mammary Stem Cells$48,119

R01 · FY2012 · CA · contact PI

BCM - LAB$1,157,200

U54 · FY2011 · CA · contact PI

Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells$446,311

R01 · FY2011 · CA

Regulation of Mammary Stem Cells$308,958

R01 · FY2011 · CA · contact PI

Education, Traning, and Outreach Program$214,333

U54 · FY2011 · CA · contact PI

Regulation of Mammary Stem Cells$48,293

R01 · FY2011 · CA · contact PI

BCM - LAB$1,317,482

U54 · FY2010 · CA · contact PI

Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells$473,769

R01 · FY2010 · CA

Regulation of Mammary Stem Cells$318,513

R01 · FY2010 · CA · contact PI

Education, Traning, and Outreach Program$233,434

U54 · FY2010 · CA · contact PI

Regulation of Mammary Stem Cells$40,023

R01 · FY2010 · CA · contact PI

Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells$478,509

R01 · FY2009 · CA

Regulation of Mammary Stem Cells$318,513

R01 · FY2009 · CA · contact PI

Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells$475,325

R01 · FY2008 · CA

Core--Animal Handling and Imaging$360,927

P01 · FY2008 · CA · contact PI

Regulation of Mammary Stem Cells$318,513

R01 · FY2008 · CA · contact PI

PTC1 Hedgehog Receptor in Mammary Ductal Development & progression to Neoplasia$287,926

P01 · FY2008 · CA · contact PI

Core--Animal Handling and Imaging$357,522

P01 · FY2007 · CA · contact PI

PTC1 Hedgehog Receptor in Mammary Ductal Development & progression to Neoplasia$285,213

P01 · FY2007 · CA · contact PI

Core--Animal Handling and Imaging$224,242

P01 · FY2006 · CA · contact PI

PTC1 Hedgehog Receptor in Mammary Development /Neoplasia$178,885

P01 · FY2006 · CA · contact PI

Core--Animal Handling and Imaging$291,960

P01 · FY2005 · CA

PTC1 Hedgehog Receptor in Mammary Development /Neoplasia$173,677

P01 · FY2005 · CA

Core--Animal Handling and Imaging$211,368

P01 · FY2004 · CA

PTC1 Hedgehog Receptor in Mammary Development /Neoplasia$168,617

P01 · FY2004 · CA

Core--Animal Handling$149,976

P01 · FY2002 · HD

Core--Animal Handling$149,976

P01 · FY2001 · HD

Core--Animal Handling$149,976

P01 · FY2000 · HD